Spyglass Pharma Stock

Spyglass Pharma provides medicine for ophthalmic diseases.

Sign up today and learn more about Spyglass Pharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Spyglass Pharma Stock

Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.

Funding History

June 2019$6.0M
January 2021$13.7M
July 2023$90.0M

Management

Co-Founder and CTO

Glenn Sussman

CEO

Patrick Mooney

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo